Briefing: Biotech Investors Urge Trump Amid M&A Activity
Strategic angle: Smaller biotechs negotiate with the White House while addressing the trust gap in medicine.
Editorial Staff
1 min read
Updated 3 months ago
Biotech investors are seeking dialogue with the Trump administration.
A significant week for mergers and acquisitions in the biotech sector.
Concerns over the trust gap in the medical field are highlighted.